store at low temperature
KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 monoclonal antibody that targets the inducible costimulatory receptor (ICOS). This compound selectively depletes cells with high ICOS expression through antibody-dependent cellular cytotoxicity (ADCC), mediated by FcγRIIIa engagement. Meanwhile, it acts as a costimulatory molecule for cells with lower ICOS levels, such as CD8+ T Effector cells, via FcγR-dependent clustering. KY-1044 leverages varying ICOS expression levels across T-cell subsets to enhance the intratumoral immune milieu and reinvigorate antitumor immune responses [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 monoclonal antibody that targets the inducible costimulatory receptor (ICOS). This compound selectively depletes cells with high ICOS expression through antibody-dependent cellular cytotoxicity (ADCC), mediated by FcγRIIIa engagement. Meanwhile, it acts as a costimulatory molecule for cells with lower ICOS levels, such as CD8+ T Effector cells, via FcγR-dependent clustering. KY-1044 leverages varying ICOS expression levels across T-cell subsets to enhance the intratumoral immune milieu and reinvigorate antitumor immune responses [1]. |
In vitro | KY-1044 (Alomfilimab; SAR 445256; 0-100ng/mL; 4 hours) induces potent antibody-dependent cellular cytotoxicity (ADCC) mediated killing in human natural killer (NK) cells expressing hICOS at an effector to target cell ratio of 5:1, with an EC50 value of 5.6 pmol/L [1]. |
In vivo | KY-1044 (Alomfilimab; SAR 445256; 10 mg/kg; intraperitoneal injection; bi-weekly for 3 weeks) as a monotherapy, with mIgG2a (effector function-enabled), effectively inhibited tumor growth in lymphoma/multiple myeloma tumor models [1]. In syngeneic mouse tumor models, KY-1044 depleted ICOS high Treg cells and enhanced the ratio of tumor-infiltrating T Eff to Treg cells, leading to increased IFNγ and TNFα secretion by Eff cells [1]. |
Synonyms | SAR 445256, Alomfilimab |
Molecular Weight | N/A |
CAS No. | 2489390-15-8 |
store at low temperature
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KY-1044 2489390-15-8 SAR 445256 Alomfilimab inhibitor inhibit